ID: ALA4649334

Max Phase: Preclinical

Molecular Formula: C17H15BrN2O2

Molecular Weight: 359.22

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc(-c2cncn2-c2ccc(Br)cc2)c(OC)c1

Standard InChI:  InChI=1S/C17H15BrN2O2/c1-21-14-7-8-15(17(9-14)22-2)16-10-19-11-20(16)13-5-3-12(18)4-6-13/h3-11H,1-2H3

Standard InChI Key:  VBGJXRGLSOBJBC-UHFFFAOYSA-N

Associated Targets(Human)

MT4 17854 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus type 1 integrase 9041 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Human immunodeficiency virus 1 70413 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 359.22Molecular Weight (Monoisotopic): 358.0317AlogP: 4.32#Rotatable Bonds: 4
Polar Surface Area: 36.28Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.58CX LogP: 3.76CX LogD: 3.75
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.70Np Likeness Score: -0.79

References

1. Rashamuse TJ, Harrison AT, Mosebi S, van Vuuren S, Coyanis EM, Bode ML..  (2020)  Design, synthesis and biological evaluation of imidazole and oxazole fragments as HIV-1 integrase-LEDGF/p75 disruptors and inhibitors of microbial pathogens.,  28  (1): [PMID:31753802] [10.1016/j.bmc.2019.115210]

Source